Tag: Cardiol Therapeutics Inc.
April 1, 2020
Cardiol Therapeutics Announces Study Results Confirm the Cardioprotective Role of its Pharmaceutical Cannabidiol Formulation in a Model of Heart Failure
Data Accepted for Presentation at the American College of Cardiology Annual Meeting March 27, 2020
Cardiol Therapeutics Announces Filing of 2019 Year-End Financial Statements and MD&A
Cardiol Therapeutics Inc. filed its audited Year-end Financial Statements and Management's Discussion and Analysis for the year ended December 31,...
March 20, 2020
Cannabis Big News Roundup: Khiron Readies for First Medical Sales in Colombia, Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers
In case you missed it, here is this week’s cannabis big news roundup. March 18, 2020
Cardiol Therapeutics Signs Supplier Agreement with Medical Cannabis by Shoppers, a Subsidiary of Shoppers Drug Mart Inc.
Cardiol Therapeutics Inc. has signed a supplier agreement to offer its pharmaceutically produced cannabidiol to Medical Cannabis by Shoppers. March 5, 2020
Cardiol Therapeutics Receives Health Canada Approval for Phase 1 Study of its Pharmaceutically Produced Cannabidiol (CBD) Formulation
Cardiol Therapeutics has received a No Objection Letter from Health Canada to conduct a Phase 1 study of its pharmaceutically...
January 15, 2020
Cardiol Therapeutics’ Exclusive Manufacturing Partner Receives Three-Year Renewal and Amendment of its Cannabis Act License from Health Canada
Dalton Pharma Services, has received a three-year renewal and license amendment of its Cannabis Act Processing License from Health Canada. December 18, 2019